Lobe Sciences (GTSIF) News Today $0.02 0.00 (-5.00%) (As of 12/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChart All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Researchers clarify the function of highly specialized nerve cells in memorySeptember 11, 2024 | msn.comLobe Sciences Announces Creation of Wholly Owned Subsidiary, Alera Pharma, Inc.August 21, 2024 | financialpost.comLobe Sciences Announces Strategic Control ShiftMay 24, 2024 | nasdaq.comLobe Sciences, Ltd. Provides Update on VitamindMay 5, 2023 | finance.yahoo.comLobe Sciences Stock (OTC:LOBEF), DividendsApril 21, 2023 | benzinga.comChronic Cluster Headaches No More: The Promise Of Lobe Sciences' At-Home Psychedelic Treatments Without The Trip!March 11, 2023 | finance.yahoo.comLobe Sciences to advance two new chemical entities through exclusive agreement with Quality Chemical LaboratoriesFebruary 23, 2023 | proactiveinvestors.comLobe Sciences Board of Directors Elects to Receive Shares in Lieu of Cash for All Board FeesJanuary 26, 2023 | benzinga.comLobe Sciences Ltd. (LOBE.CN)November 8, 2022 | finance.yahoo.comLobe Sciences Announces Roadmap for Remainder of 2022 and Early 2023June 16, 2022 | finance.yahoo.comLobe Sciences plans to advance to Phase 1 PTSD study in second half of 2022 with psilocybin and NACMarch 30, 2022 | proactiveinvestors.comLobe Sciences Ltd. (LOBEF)December 10, 2021 | finance.yahoo.comLobe Sciences Announces Common Stock to Trade Under the Symbol "LOBEF" in US MarketsNovember 15, 2021 | finance.yahoo.comLobe Sciences Invites You to Join Us at the Q4 Virtual Investor SummitNovember 8, 2021 | finance.yahoo.comLobe Announces Krysalis VX Innovations Inc., a Company Equally Owned by Lobe Sciences Ltd. and Virtual Psychedelics Incorporated, Appointment of Interdisciplinary Team of AdvisorsOctober 6, 2021 | finance.yahoo.comLobe Sciences to Present at the BioFuture 2021 & MoneyShow Virtual Expo Investor ConferencesOctober 5, 2021 | finance.yahoo.comLobe Sciences and the World Boxing Association Announce Initiative Targeting mTBI and PTSDOctober 4, 2021 | finance.yahoo.comLobe Sciences Announces Data Demonstrating That Its Combination Therapeutic Candidates are Significantly More Effective Than Monotherapy in mTBI and PTSDSeptember 28, 2021 | finance.yahoo.comLobe Sciences to Present at the Benzinga Healthcare Small Cap ConferenceSeptember 27, 2021 | finance.yahoo.comLobe Sciences Ltd.: Lobe Sciences to Participate at the Advances in Mental Health Psychedelics and Non-Psychedelics ConferenceSeptember 16, 2021 | finanznachrichten.deLobe Sciences to Participate at the Advances in Mental Health Psychedelics and Non-Psychedelics ConferenceSeptember 15, 2021 | finance.yahoo.comLobe Sciences Provides Corporate Update to Investors and StakeholdersSeptember 13, 2021 | finance.yahoo.comLobe Sciences to Present At H.C. Wainwright 23rd Annual Global Investment ConferenceSeptember 10, 2021 | finance.yahoo.comBeyoncé Channeled Audrey Hepburn in a Chic LBD and 128.54 Carat "Tiffany Diamond" NecklaceAugust 25, 2021 | yahoo.comLobe Sciences Appoints Albert "Skip" Rizzo, Ph.D to Scientific Advisory BoardAugust 23, 2021 | finance.yahoo.com Get Lobe Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GTSIF and its competitors with MarketBeat's FREE daily newsletter. Email Address ⭕ [URGENT] Buy Alert just triggered (Ad)My absolute favorite stock just hit a critical "buy now" trigger price. Click here for the ticker >>> GTSIF Media Mentions By Week GTSIF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GTSIF News Sentiment▼0.000.60▲Average Medical News Sentiment GTSIF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GTSIF Articles This Week▼00▲GTSIF Articles Average Week Get Lobe Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GTSIF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TGIFF News Today FFNTF News Today ABSCF News Today ACRHF News Today ACRDF News Today LBTSF News Today AZFL News Today ERBB News Today AWWH News Today AVTBF News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:GTSIF) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lobe Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lobe Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
